TY - JOUR
T1 - Prevalence of chronic obstructive pulmonary disease in Fez, Morocco
T2 - Results from the BOLD study
AU - El Rhazi, K.
AU - Nejjari, C.
AU - Ben Jelloun, M. C.
AU - El Biaze, M.
AU - Attassi, M.
AU - Garcia-Larsen, V.
N1 - Publisher Copyright:
© 2016 The Union.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Objective: To present population-estimated prevalence of spirometrically confirmed chronic obstructive pulmonary disease (COPD) in adults (age 740 years), living in the city of Fez, Morocco. D E S IGN: Following the Burden of Lung Disease (BOLD) methodology, population-based sampling plans were used for the recruitment of eligible adults. The study collected questionnaire data on respiratory symptoms, medical history, health status, exposure to risk factors for COPD and quality of life. Post-bronchodilator spirometry was performed and COPD and its stages were defined according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Results: Among 768 individuals with valid data and acceptable quality post-bronchodilator spirometry results, the overall prevalence of stage 1 or higher COPD was 12.6%. The prevalence of GOLD stage 2 or higher COPD was 7.9%. The population-estimated prevalence of lower limit of normal (LLN) modified stage 1 or higher COPD was 8% among non-smokers, and it increased with number of pack-years (17.8% for.20 pack-years vs. 3.8% for,10 pack-years). The prevalence of physician-diagnosed COPD was 3.2%; this was associated with an increase in smoking pack-years. Conclusion: These results emphasise the urgent need to take necessary measures to reduce the prevalence of tobacco smoking.
AB - Objective: To present population-estimated prevalence of spirometrically confirmed chronic obstructive pulmonary disease (COPD) in adults (age 740 years), living in the city of Fez, Morocco. D E S IGN: Following the Burden of Lung Disease (BOLD) methodology, population-based sampling plans were used for the recruitment of eligible adults. The study collected questionnaire data on respiratory symptoms, medical history, health status, exposure to risk factors for COPD and quality of life. Post-bronchodilator spirometry was performed and COPD and its stages were defined according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Results: Among 768 individuals with valid data and acceptable quality post-bronchodilator spirometry results, the overall prevalence of stage 1 or higher COPD was 12.6%. The prevalence of GOLD stage 2 or higher COPD was 7.9%. The population-estimated prevalence of lower limit of normal (LLN) modified stage 1 or higher COPD was 8% among non-smokers, and it increased with number of pack-years (17.8% for.20 pack-years vs. 3.8% for,10 pack-years). The prevalence of physician-diagnosed COPD was 3.2%; this was associated with an increase in smoking pack-years. Conclusion: These results emphasise the urgent need to take necessary measures to reduce the prevalence of tobacco smoking.
KW - BOLD study
KW - COPD prevalence
KW - Morocco CHRONIC OBSTRUCTIVE pulmonary disease
UR - http://www.scopus.com/inward/record.url?scp=84951997433&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951997433&partnerID=8YFLogxK
U2 - 10.5588/ijtld.15.0029
DO - 10.5588/ijtld.15.0029
M3 - Article
C2 - 26688540
AN - SCOPUS:84951997433
SN - 1027-3719
VL - 20
SP - 136
EP - 141
JO - International Journal of Tuberculosis and Lung Disease
JF - International Journal of Tuberculosis and Lung Disease
IS - 1
ER -